On Neogenomics’ last earnings conference call they repeatedly referred to several new proprietary tests, developed with the help of a strategic partner.
I realize this is not an investing forum, but as a small investor I thought, great! The specialized a/p sector is very competitive, and thought this was a great development and a way to further differentiate themselves.
Does anyone closer to this company know if this is going to happen?
The CEO said (of this partner) this technology would be “transformative” for Neo. Pretty lofty prose.
I realize this is not an investing forum, but as a small investor I thought, great! The specialized a/p sector is very competitive, and thought this was a great development and a way to further differentiate themselves.
Does anyone closer to this company know if this is going to happen?
The CEO said (of this partner) this technology would be “transformative” for Neo. Pretty lofty prose.